Breckenridge Recalls One Lot of Propranolol ER Capsules Due to Metal Contamination Risk
Breckenridge Pharmaceutical, Inc. is voluntarily recalling one lot of propranolol hydrochloride extended-release capsules, 60 mg, to the consumer level in the United States. The product, manufactured by Adare Pharma Solutions, is being recalled because of potential contamination with metal particles.
Taking capsules from the affected batch could potentially result in lacerations of soft tissues within the oral cavity, esophagus, stomach, or intestines. The issue arose because the lot shared intermediate processing material linked to metal contamination found in an unreleased batch. Breckenridge reported that no adverse events related to the recalled lot have been documented to date.
Patients taking medication from the affected lot are advised to discontinue use immediately, return any remaining capsules to the dispensing pharmacy, and contact their physician for alternative treatment. Wholesalers and pharmacies are instructed to immediately quarantine the product and stop all distribution and dispensing.
Key points
- Breckenridge recalled 100-count bottles of propranolol hydrochloride extended-release 60 mg capsules, lot PK25110035 (NDC 51991-817-01, expiration May 2029).
- The recall was prompted by potential metal contamination traced to shared intermediate material.
- Potential clinical risks include mechanical injury or laceration to the oral cavity and gastrointestinal tract.
- No adverse events have been reported to date in connection with the recalled batch.
What it means for you
Clinicians and pharmacists in Pakistan should be aware of this foreign recall involving US-distributed propranolol extended-release capsules. Practitioners advising patients who source medicines internationally should check packaging for the affected lot number, and consult the Drug Regulatory Authority of Pakistan (DRAP) for local product registrations and safety advisories.
Breckenridge Pharmaceutical, Inc. Issues Voluntary Nationwide Consumer-Level Recall of One Lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, Due to Potential Metal Contamination
Summarised automatically from the official announcement. For educational purposes only — check the original source before making clinical decisions.
